Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 20, 2022

Primary Completion Date

November 19, 2024

Study Completion Date

November 19, 2026

Conditions

Esophageal Squamous Cell CarcinomasConcurrent ChemoradiotherapyImmunotherapyChemotherapy

Interventions

DRUG

chemotherapy combined with PD-1 inhibitors

Induction chemotherapy combined with PD-1 inhibitors followed with standard concurrent chemoradiotherapy

All Listed Sponsors

lead

Shanghai Chest Hospital

OTHER